by Eric Christianson | Mar 10, 2021 | Clinical Guideline Updates For Pharmacists
There are a few important heart failure guideline updates in the works to the American College of Cardiology’s Heart Failure Guidelines, last published in 2013. Prior to the full guideline release, the organization recently printed their updated Expert Consensus...
by Eric Christianson | Mar 7, 2021 | Drug Interaction Case Studies and Education For Pharmacists
It is critical to remember that lithium toxicity can result due to numerous possible drug interactions. Here’s a case scenario where lithium toxicity was caused by a thiazide diuretic. KE is a 44-year-old male with a history of bipolar disorder. Symptoms have...
by Eric Christianson | Mar 3, 2021 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Obesity is a major risk factor for many comorbidities (hypertension, dyslipidemia, osteoarthritis, sleep apnea, heart disease, type 2 diabetes) and increases all-cause and cardiovascular mortality. With over 40% of Americans qualifying as obese (body mass index ≥30...
by Eric Christianson | Feb 28, 2021 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
A new treatment for chronic weight management is likely on the way. In a recent trial, investigators looked at semaglutide for weight loss. The final results of the STEP1 trial (Semaglutide Treatment Effect in People with obesity) were recently reported in the New...
by Eric Christianson | Feb 24, 2021 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Parkinson’s disease (PD) has long presented challenges in medication delivery. A staple in more advanced disease control, carbidopa-levodopa requires multiple daily dosing with supratherapeutic levels leading to dyskinesias and subtherapeutic concentrations leading to...
